Paired protein kinases PRKCI-RIPK2 promote pancreatic cancer growth and metastasis via enhancing NF-κB/JNK/ERK phosphorylation

[1]  S. Chauhan,et al.  Selective autophagy of RIPosomes maintains innate immune homeostasis during bacterial infection , 2022, The EMBO journal.

[2]  G. Song,et al.  Laminarin Attenuates ROS-Mediated Cell Migration and Invasiveness through Mitochondrial Dysfunction in Pancreatic Cancer Cells , 2022, Antioxidants.

[3]  Runyu Yang,et al.  Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction , 2022, Molecular medicine.

[4]  Ruifeng Liu,et al.  A pancancer analysis of the carcinogenic role of receptor-interacting serine/threonine protein kinase-2 (RIPK2) in human tumours , 2022, BMC medical genomics.

[5]  D. Di Vizio,et al.  Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis , 2022, Nature Communications.

[6]  Qian Zhang,et al.  Identification of an Autophagy-Related Pair Signature for Predicting Prognoses and Immune Activity in Pancreatic Adenocarcinoma , 2021, Frontiers in Immunology.

[7]  Xianglan Zhang,et al.  SPOCK1 promotes metastasis in pancreatic cancer via NF-κB-dependent epithelial-mesenchymal transition by interacting with IκB-α , 2021, Cellular Oncology.

[8]  U. Boggi,et al.  Evolving pancreatic cancer treatment: From diagnosis to healthcare management. , 2021, Critical reviews in oncology/hematology.

[9]  V. Krajka-Kuźniak,et al.  Attenuation of Pancreatic Cancer In Vitro and In Vivo via Modulation of Nrf2 and NF-κB Signaling Pathways by Natural Compounds , 2021, Cells.

[10]  T. Zhu,et al.  PKCι regulates the expression of PDL1 through multiple pathways to modulate immune suppression of pancreatic cancer cells. , 2021, Cellular signalling.

[11]  Lilong Zhang,et al.  Receptor-interacting protein in malignant digestive neoplasms , 2021, Journal of Cancer.

[12]  K. Lim,et al.  Stroma-targeting strategies in pancreatic cancer: Past lessons, challenges and prospects , 2021, World journal of gastroenterology.

[13]  G. Gabriely,et al.  MicroRNA-146a limits tumorigenic inflammation in colorectal cancer , 2021, Nature Communications.

[14]  Lianyu Chen,et al.  Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling , 2021, BMC Cancer.

[15]  Mengyao Sun,et al.  Phosphorylation of the Regulators, a Complex Facet of NF-κB Signaling in Cancer , 2020, Biomolecules.

[16]  Hui Wang,et al.  TRPM2 promotes pancreatic cancer by PKC/MAPK pathway , 2020, Cell Death & Disease.

[17]  Zhiqiang Li,et al.  Autophagy Regulatory Genes MET and RIPK2 Play a Prognostic Role in Pancreatic Ductal Adenocarcinoma: A Bioinformatic Analysis Based on GEO and TCGA , 2020, BioMed research international.

[18]  T. Zhu,et al.  Transcription factor Sp1 is upregulated by PKCι to drive the expression of YAP1 during pancreatic carcinogenesis. , 2020, Carcinogenesis.

[19]  F. Brunicardi,et al.  Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia , 2020, International journal of molecular sciences.

[20]  M. Barbacid,et al.  Targeting the MAPK Pathway in KRAS-Driven Tumors. , 2020, Cancer cell.

[21]  K. Kuča,et al.  Selective inhibitors for JNK signalling: a potential targeted therapy in cancer , 2020, Journal of enzyme inhibition and medicinal chemistry.

[22]  T. Zhu,et al.  Mu‐KRAS attenuates Hippo signaling pathway through PKCι to sustain the growth of pancreatic cancer , 2020, Journal of cellular physiology.

[23]  Chenlin Gao,et al.  RIPK2-Mediated Autophagy and Negatively Regulated ROS-NLRP3 Inflammasome Signaling in GMCs Stimulated with High Glucose , 2019, Mediators of inflammation.

[24]  P. V. Bramhachari,et al.  Small molecule tyrosine kinase inhibitors and pancreatic cancer-Trials and troubles. , 2019, Seminars in cancer biology.

[25]  J. Kwiatkowski,et al.  Fragment-based Discovery of a Small-Molecule Protein Kinase C-iota Inhibitor Binding Post-kinase Domain Residues. , 2019, ACS medicinal chemistry letters.

[26]  T. Kufer,et al.  XIAP controls RIPK2 signaling by preventing its deposition in speck-like structures , 2019, Life Science Alliance.

[27]  Sarah I. Alothman,et al.  The Necrosome Promotes Pancreas Oncogenesis via CXCL1 and Mincle Induced Immune Suppression , 2016, Nature.

[28]  M. Lamkanfi,et al.  Reactive Oxygen Species Regulate Caspase-11 Expression and Activation of the Non-canonical NLRP3 Inflammasome during Enteric Pathogen Infection , 2014, PLoS pathogens.

[29]  J. Bertin,et al.  The immune receptor NOD1 and kinase RIP2 interact with bacterial peptidoglycan on early endosomes to promote autophagy and inflammatory signaling. , 2014, Cell host & microbe.

[30]  J. Shay,et al.  Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways , 2014, Breast Cancer Research.

[31]  Paul G. Thomas,et al.  Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infection , 2013, Nature Immunology.

[32]  O. Rath,et al.  MAP kinase signalling pathways in cancer , 2007, Oncogene.

[33]  S. Cowan-Jacob,et al.  Structural biology of protein tyrosine kinases , 2006, Cellular and Molecular Life Sciences CMLS.

[34]  C. Der,et al.  Targeting the ERK mitogen-activated protein kinase cascade for the treatment of KRAS-mutant pancreatic cancer. , 2022, Advances in cancer research.

[35]  Nicole M. Baker,et al.  Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer. , 2019, Cancer discovery.

[36]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..